BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 15173019)

  • 21. Identification of genes correlated with early-stage bladder cancer progression.
    Stone R; Sabichi AL; Gill J; Lee IL; Adegboyega P; Dai MS; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Cancer Prev Res (Phila); 2010 Jun; 3(6):776-86. PubMed ID: 20501863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray.
    Ewis AA; El-Samman E; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Kanayama HO; Baba Y
    Urol Oncol; 2007; 25(2):120-7. PubMed ID: 17349526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Identification of gene expression patterns in superficial and invasive human bladder cancers].
    Zhou L; Shi BT; Wang SX; Luo Y; Yang L; Zhang LL; Wang XY; He DL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):798-801. PubMed ID: 17565857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
    Dhawan D; Hamdy FC; Rehman I; Patterson J; Cross SS; Feeley KM; Stephenson Y; Meuth M; Catto JW
    J Pathol; 2006 Jul; 209(3):336-43. PubMed ID: 16639696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS; Lee JH; Yu HS; Choi YD
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
    Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
    Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
    Dyrskjøt L; Zieger K; Real FX; Malats N; Carrato A; Hurst C; Kotwal S; Knowles M; Malmström PU; de la Torre M; Wester K; Allory Y; Vordos D; Caillault A; Radvanyi F; Hein AM; Jensen JL; Jensen KM; Marcussen N; Orntoft TF
    Clin Cancer Res; 2007 Jun; 13(12):3545-51. PubMed ID: 17575217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
    Retz M; Lehmann J; Röder C; Plötz B; Harder J; Eggers J; Pauluschke J; Kalthoff H; Stöckle M
    Cancer Res; 1998 Dec; 58(24):5662-6. PubMed ID: 9865718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
    Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
    Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.
    Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A
    Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.
    Hara T; Takahashi M; Gondo T; Nagao K; Ohmi C; Sakano S; Naito K; Matsuyama H
    Int J Urol; 2009 Mar; 16(3):293-8. PubMed ID: 19207607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic radical cystoprostatectomy: our experience in a consecutive series of 10 patients with a 3 years follow-up.
    Simonato A; Gregori A; Lissiani A; Bozzola A; Galli S; Gaboardi F
    Eur Urol; 2005 Jun; 47(6):785-90; discussion 790-2. PubMed ID: 15925074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.